An Efficient Method for Generation of Knockout Human Embryonic Stem Cells Using CRISPR/Cas9 System.

Area of Science:

• Stem Cell Biology
• Gene Editing Technologies
• Developmental Biology

Background:

• Human embryonic stem cells (hESCs) are valuable for studying gene function, disease modeling, and therapeutic development.
• Gene editing techniques like CRISPR/Cas9 offer powerful tools for hESC modification.
• Generating null alleles for gene disruption in hESCs can be inefficient and time-consuming.

Purpose of the Study:

• To develop a simple and efficient protocol for permanently downregulating gene expression in hESCs.
• To establish a robust method for targeting specific genes, using p53 as a proof of concept.
• To demonstrate that genetically modified hESCs retain essential stem cell characteristics.

Main Methods:

• Utilized CRISPR/Cas9 gene editing technology for gene downregulation in hESCs.
• Employed a series of hESC transfection steps to achieve targeted gene silencing.
• Validated gene downregulation by assessing p53 protein levels and the expression of its target gene, miR-34a.

Main Results:

• Achieved efficient downregulation of p53 expression, even in polyclonal hESC populations (p53 Low cells).
• Demonstrated over 80% efficiency in generating hESC clonal sublines lacking p53 protein expression.
• Confirmed that genetically modified hESCs maintained typical stem cell characteristics through functional experiments.

Conclusions:

• Provided a simple, robust, and efficient protocol for targeting gene expression in hESCs using CRISPR/Cas9.
• The developed method facilitates the generation of hESC lines with downregulated genes of interest.
• This protocol is beneficial for laboratories utilizing gene editing in hESC research and applications.